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Abstract
Introduction: There are only limited data on the long-term outcome of patients receiving specialized neurocritical
care. In this study we analyzed survival, long-term mortality and functional outcome after neurocritical care and
determined predictors for good functional outcome.
Methods: We retrospectively investigated 796 consecutive patients admitted to a non-surgical neurologic intensive
care unit over a period of two years (2006 and 2007). Demographic and clinical parameters were analyzed.
Depending on the diagnosis, we grouped patients according to their diseases (cerebral ischemia, intracranial
hemorrhage (ICH), subarachnoid hemorrhage (SAH), meningitis/encephalitis, epilepsy, Guillain-Barré syndrome (GBS)
and myasthenia gravis (MG), neurodegenerative diseases and encephalopathy, cerebral neoplasm and intoxication).
Clinical parameters, mortality and functional outcome of all treated patients were analyzed. Functional outcome
(using the modified Rankin Scale, mRS) one year after discharge was assessed by a mailed questionnaire or
telephone interview. Outcome was dichotomized into good (mRS ≤ 2) and poor (mRS ≥ 3). Logistic regression
analyses were calculated to determine independent predictors for good functional outcome.
Results: Overall in-hospital mortality amounted to 22.5% of all patients, and a good long-term functional outcome
was achieved in 28.4%. The parameters age, length of ventilation (LOV), admission diagnosis of ICH, GBS/MG, and
inoperable cerebral neoplasm as well as Therapeutic Intervention Scoring System (TISS)-28 on Day 1 were
independently associated with functional outcome after one year.
Conclusions: This investigation revealed that age, LOV and TISS-28 on Day 1 were strongly predictive for the
outcome. The diagnoses of hemorrhagic stroke and cerebral neoplasm leading to neurocritical care predispose for
functional dependence or death, whereas patients with GBS and MG are more likely to recover after neurocritical
care.
Introduction
Within the last decades, specialized neurocritical inten-
sive care units (NICU) have evolved from bigger, multi-
disciplinary ICUs [1]. This specialization has led to a
decrease in both in-hospital mortality and length of hos-
pital stay without associated effects on readmission rates
and long-term mortality [2]. Nevertheless, case fatality
of patients admitted to NICUs is still high and the out-
come often poor [3]. Yet, there are still little data on
clinical parameters associated with long-term outcome
after neurocritical care; aside from age, the major
determinant for outcome, hospital length of stay and the
diagnosis of stroke have been shown to negatively influ-
ence outcome [3].
In order to provide data that facilitate the assessment
of long-term prognosis after neurocritical care we aimed
to identify predisposing factors for a good functional
recovery one year after treatment on a specialized
neurocritical care unit.
Materials and methods
Patients and setting
The present analysis was based on patients who were
admitted to our 10-bed NICU (University Hospital
Erlangen, Tertiary University Hospital) in 2006 and
2007. Given a separate neurosurgical ICU on the same
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matic brain injury are not treated in our NICU. Because
there is an additional 14-bed stroke and intermediate
care unit, according to an institutional protocol, all
patients admitted to our NICU must fulfill at least one
of the following criteria: requiring mechanical ventila-
tion, intravenous catecholamines, extraventricular or
lumbar drainages, or have a Glasgow Coma Scale (GCS)
below or equal to nine points. Furthermore, patients
with evidence of vasospasms were also treated in our
NICU. According to an inter-institutional protocol,
patients with subarachnoid hemorrhage (SAH) who
were treated endovascularly were admitted to our
NICU, whereas SAH patients who were treated surgi-
cally were admitted to the neurosurgical ICU. Likewise,
patients with brain tumors at operable stages were trea-
ted neurosurgically; those who were not operable, were
treated neurologically.
Seven-hundred and ninety-six neurological patients
were admitted over the two-year period, representing
our intention-to-treat cohort. Detailed data on this
group are given in Figure 1 and Table 1. To more reli-
ably analyze prediction of functional outcome we
focussed on those patients who received specialized
neurocritical care and excluded all patients who were
set on do not treat (DNT) orders at admission. Patients
who were set on DNT orders were most severely
affected (for example, signs of herniation on admission
because of massive ICH) or they had severe co-morbid-
ities and did not consent to invasive critical care thera-
pies. These patients did not receive any treatment,
except for intravenous fluids and morphine, and were
only admitted to our neurocritical care unit because of
already having been intubated and ventilated prior to
hospital arrival. We determined ap r i o r ito focus on
treated patients only and thus excluded patients with
early DNT orders from our analysis of functional out-
come after specialized neurocritical care. Contrary to
this, patients who received any other therapeutic proce-
dure are not referred to as DNT and remained in our
analysis. Furthermore, we excluded all patients who
were monitored on our NICU only temporarily either
as outsourced patients from other ICUs or because of
elective neuroradiologic procedures; that is, patients
who were monitored for only few hours until extubation
after intracranial stenting or coiling (Figure 1). More-
over, patients that were lost to follow-up at one year
after discharge were excluded (n = 29; the baseline clin-
ical data as well as in-hospital mortality of patients lost
to follow-up did not vary significantly from the cohort
Figure 1 Flowchart of patient selection.
Kiphuth et al. Critical Care 2010, 14:R136
http://ccforum.com/content/14/4/R136
Page 2 of 8analyzed (data not shown). Overall, 666 patients
remained for final analysis and we refer to this group as
the per protocol cohort. The institutional review board
approved the study and consent was obtained in written
or oral form from all patients or their relatives/legal
guardians.
Data collection and outcome analysis
The parameters of age, sex, pre-admission mRS, length
of hospital stay (LOS; in days), diagnosis, duration time
of ventilation (LOV; in days) and modified TISS-28
(Therapeutic Intervention Scoring System) [4] were
obtained by reviewing the patients’ hospital charts and
institutional electronic databases. Mortality and func-
tional outcome one year after discharge (as modified
Rankin Scale (mRS)) were obtained by a mailed standar-
dized questionnaire. In all cases in which this question-
naire did not return within six weeks, a standardized
phone interview was conducted with the patients, or
their closest relatives, respectively [5]. The telephone
interviews were performed by one physician who was
trained and certified for data collection on disability,
quality of life, and the mRS.
Given the heterogeneous patient population we
grouped the patients with respect to their diagnoses
(ischemic stroke, intracranial hemorrhage (ICH), subar-
achnoid hemorrhage (SAH), epileptic seizures, menin-
goencephalitis, Guillain-Barré syndrome (GBS) and
Myasthenia gravis (MG), neurodegeneration/encephalo-
pathy, inoperable cerebral neoplasm, and intoxication).
Table 1 Demographic and clinical data
All Ischemia ICH SAH Meningoencephalitis Epilepsy GBS/
MG
Neurodeg/
Encephalopathy
Neoplasm Intoxication Temporarily
monitored
n (%) 733 247
(33.7)
210
(27.4)
38
(5.2)
49 (6.7) 93 (12.7) 25
(3.4)
22 (3.0) 22 (3.0) 27 (3.7) 63
Age (median,
range)
67
(18
to
95)
72 (21 to
93)
70
(35 to
95)
56
(19
to
84)
63 (27 to 85) 59 (18
to 93)
58
(23
to
78)
66 (23 to 90) 65 (39 to
78)
53 (29 to
78)
51 (33 to
68)
Female sex
(n, %)
350
(47.7)
111 (44.9
)
100
(47.6)
20
(52.6)
26 (53.1) 48 (51.6) 14
(56)
14 (63.6) 8 (36.4) 9 (33.3) 26 (41.3)
Pre-hospital
mRS 0 to 2 n
(%)
635
(86.6)
227
(91.9)
198
(94.3)
37
(97.4)
43 (87.8) 71 (76.3) 24
(96.0)
8 (36.4) 4 (18.2) 23 (85.2) 47 (74.6)
Hospital
length of
stay in days
(median,
range)
4( 0
to
87)
4( 0t o
57)
5( 0
to 53)
4( 0
to
63)
4( 0t o8 4 ) 1( 0t o
87)
6( 0
to
57)
3 (1 to 50) 3 (0 to 17) 3 (0 to 19) 1( 0t o2 )
Mechanichal
ventilation
(n, %)
450
(61.4)
148
(59.9)
140
(66.7)
20
(52.6)
42 (85.7) 48 (51.6) 16
(64.0)
18 (81.8) 8 (36.4) 20 (74.1) 18 (28.6)
Length of
ventilation
(d) (median,
range)
3( 0
to
83)
4( 0t o
43)
5( 0
to 53)
1(0
to
60)
4( 0t o8 3 ) 0( 0t o
63)
6( 0
to
49)
3 (0 to 50) 0 (0 to 13) 3 (0 to 14) 0( 0t o1 )
DNT (n, %) 38
(5.1)
9 (3.6) 22
(10.5)
3
(7.9)
0 0 0 2 (9.1) 2 (9.1) 0 0
Lost to
follow-up (n,
%)
29
(4.0)
6 (2.4) 5
(2.4)
1
(2.6)
2 (4.1) 7 (7.5) 1 (4) 2 (9.1) 3 (13.6) 2 (7.4) 16 (25.4)
In-hospital
mortality (n,
%)
165
(22.5)
53 (21.5) 75
(35.7)
12
(31.6)
3 (6.1) 5 (5.4) 1
(4.0)
4 (18.2) 7 (31.8) 5 (18.5) 0
Mortality
after 1 year
(n, %)
292
(39.8)
100
(41.5)
121
(59.0)
18
(48.6)
6 (12.8) 14 (16.3) 1
(4.2)
11 (55.0) 15 (78.9) 6 (24.6) 1 (2.1)
mRS 0 to 2
after 1 year
(n, %)
208
(28.4)
33 (13.7) 40
(19.5)
11
(29.7)
28 (59.6) 57 (66.3) 16
(66.7)
5 (25.0) 1 (5.3) 17 (68.0) 38 (80.9)
Demographic and clinical characteristics of all patients (n = 796) including a separate analysis for admission diagnosis (intention-to-treat cohort).
Patients who were excluded for the per protocol-analysis are highlighted in bold. (PS: All patients monitored only temporarily (right column) are not included in
the overall numbers (left column). Patients lost to follow up are not included in mortality and functional outcome after one year.)
Abbreviations: ICH, intracranial hemorrhage; SAH, subarachnoid hemorrhage; GBS, Guillain-Barré syndrome; MG, myasthenia gravis; Neurodeg, neurodegenerative
disease; n, number; d, days.
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independent) or poor (mRS 3 to 6; dependent or dead).
In addition, in-hospital mortality and the mortality rates
one year after discharge were assessed.
Statistical analysis
Statistical analyses were performed using the SPSS 17.0
software package (SPSS Inc., Chicago, IL, USA). Statisti-
cal tests were two-sided and the significance level was
set at a = 0.05. The distribution of the data was
assessed with the Kolmogorov-Smirnov test. Continuous
and categorical variables are expressed as mean and SD,
as median and range, or as percentage, as appropriate.
Proportions between two groups were compared by
using the c2 test, Fisher’s exact test or Mann-Whitney
U test, as appropriate.
One stepwise forward inclusion multivariate logistic
regression model was calculated for prediction of good
functional outcome one year after neurocritical care
including those parameters that showed at least a trend
when being tested univariately (P < 0.1). Interaction
terms did not reveal significant interaction between the
variables. In the univariate and multivariate analyses, the
parameters LOS and LOV were calculated as dichto-
mized variables (according to their median); however,
LOV was also calculated as a continuous variable (that
is, increasing days) in the univariate analysis. The modi-
fied TISS-28 score is given as value per day and was
categorized (< 21, 21 to 40, > 40), as described pre-
viously [3].
Results
Analysis of all patients admitted to the neurocritical care
unit (Intention-to-treat population)
The demographic and clinical characteristics of all 796
patients are given in Table 1. The analysis according to
admission diagnoses revealed that nearly 60% of all
patients suffered from stroke (ischemic stroke: n = 247;
31% and ICH: n = 210; 26%). Patients were diagnosed
with SAH in 5% (n = 38), epileptic seizures in 12% (n =
93), meningoencephalitis in 6% (n = 49), Guillain-Barré-
Syndrome and myasthenia gravis in 3% (n =2 5 ) ,n e u r o -
degenerative diseases and encephalopathy in 3% (n =
22), cerebral neoplasm in 3% (n = 22), and intoxications
in 3% (n = 27). The remaining 63 patients were patients
outsourced from general ICUs due to space limitations
as well as patients temporarily monitored after neurora-
diological procedures. The median length of stay was
four days (0 to 87 days). The median length of ventila-
tion was three days (0 to 83 days). The median modified
TISS-28 score on Day 1 was 38 (18 to 71), the median
TISS-28 score at discharge was 19 (15 to 43). When
only focussing on treated patients, the in-hospital mor-
tality amounted to 22.5%, and mortality rate after one
year was 39.8%. Including patients who were set on
DNT orders, the in-hospital mortality rate amounted to
27.7%, and the one-year mortality rate was 45.0%. For
more detailed data please refer to Table 1.
Analysis of patients receiving specialized neurocritical
care (per protocol population)
Figure 2 shows data on in-hospital mortality, mortality
after one year, and functional outcome one year after
neurocritical care. Overall in-hospital mortality was
19.1%, and overall mortality after one year was 38.1%.
Proportional to the patient numbers, ischemic stroke,
ICH, SAH, cerebral neoplasm, and neurodegenerative
diseases revealed the highest frequency of in-hospital
and long-term mortalities compared to the remaining
patients (P < 0.01). Overall, 31.2% of the per-protocol
population achieved a favorable functional long-term
outcome. Good functional outcome was achieved signifi-
cantly more often in patients with meningoencephalitis,
epilepsy, GBS/MG, and intoxication (P < 0.01).
Prediction of good functional long-term outcome after
neurocritical care
The logistic regression analysis of all patients who
received specialized neurocritical care for prediction of a
good functional outcome one year after discharge is
shown in Table 2. After adjustment, the diseases GBS
and MG were independently related to a good long-term
outcome, whereas age, LOV, and TISS-28 score on Day 1
as well as the diagnoses ICH and cerebral neoplasm were
predisposing factors for an unfavorable outcome.
Discussion
First of all it has to be noted that neurocritical care
medicine deals with severely ill patients with a highly
constricted capability of regeneration of neurons of the
central nervous system. Hence, neurological syndromes
due to neurovascular and inflammatory causes, which
represent the majority in this study and result in the
necessity of intensive care only show a limited capacity
of complete recovery, whereas diseases without affection
of neurons, that is, due to autoimmune causes, recovery
may not be limited [6]. Nonetheless, specialized neuro-
critical care is justified as a number of specific treatment
regimens have emerged over the past years. Examples
for specific neurocritical care therapies include hemicra-
niectomy for treatment of space-occupying large cere-
bral infarctions [7] as well as continuous intracranial
pressure and oxygen monitoring with intraparenchymal
probes [8]. Patients with basilar artery and carotid
artery-T occlusion may receive interventional treatment
with a combined approach of intravenous and intraar-
terial thrombolytics [9] with or without use of recanali-
sation devices [10]. ICH patients with intraventricular
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ventricular drainages, intraventricular thrombolysis and
lumbar drainage for communicating hydrocephalus
[11-13]. Both ischemic and hemorrhagic stroke can be
treated with endovascular cooling to reduce edema for-
mation and to reduce further impairment of so far
healthy brain tissue [14]. Furthermore, patients with
GBS are treated with plasma exchange, intravenous
immunoglobulins, ventilation and external pacemakers
for severe autonomic dysfunction [15,16]. However, the
benefit of some of these neurointensive procedures has
not been shown in large randomized trials. Furthermore,
admittance to a NICU has been shown to reduce mor-
tality and LOS and improve functional outcome as com-
pared to a general ICU [2,17-19]. These benefits are
most likely multifactorial and may be related to elevated
attention in a neurocritical care setting to factors like
reduced alertness that may result in secondary dete-
rioration as well as neuroprotective measures such as
normothermia, strict blood pressure management and
management of cerebral edema formation.
In the present study we investigated the long-term out-
come of treated patients receiving specialized neurocritical
care and identified predisposing factors for a good func-
tional outcome. As a key finding, overall outcome one
year after treatment was fairly positive with 28.4% showing
a good functional outcome of a mRS ≤ 2.
Mortality
Mortality in critical care medicine is naturally high.
Patients with hepatic encephalopathy (median age 58
years) showed a mortality rate one year after an ICU
stay that amounted to 54% [20]. In critically ill surgical
patients (mean age 65 years) survival one year after ICU
discharge was reported to be 33% [21]. A systematic
review of studies on general ICU patients showed a one
year mortality between 26 and 63% (n = 5,725, mean
age 55 years) [22]. Contrary, there are only limited data
on outcome and mortality of NICU patients. The only
available study that investigated a patient collective
comparable to ours, reported a mortality rate of 47%
after a mean follow-up time of 2.7 years [3]. In our
cohort, overall mortality one year after NICU stay was
as high as 39.8%. These rates were mainly driven by
stroke patients and those with other diseases with high
mortality rates such as neurodegenerative diseases, ence-
phalopathy and inoperable cerebral neoplasms [23].
Functional outcome and outcome-predicting diseases
Regarding the functional outcome of the surviving
patients the parameter age is the major determinant of
outcome, as described previously [3]. However, com-
pared to many non-neurological diseases, age in neuro-
logical patients is not a fixed determinant for poor
outcome but a rather relative parameter that has to be
Figure 2 Functional status after one year, in-hospital mortality and mortality after one year for all patients treated per protocol (n =
666).
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ple, reversible inflammatory disease (GBS) versus irre-
versible brain tissue damage by stroke or ICH [3,6].
Several therapies applied in neurocritical care are linked
to the age of patients. For instance, a 75-year-old patient
with malignant middle cerebral artery infarction will not
undergo hemicraniectomy because outcome likely will
be poor with or without decompressive surgery, how-
ever, this is going to be investigated in the DESTINY 2
trial (ISRCTN21702227). In contrast, a patient with GBS
of the same age will surely receive all possible critical
care treatment. Given (i) an overall younger age of the
analyzed patients of general and surgical ICU’sa sc o m -
pared to our study (that is, approximately 60 years
[20-22] versus 67 years), and (ii) the age-associated co-
morbidity of our patients, the functional outcome data
presented here are respectable. In addition, functional
outcome was significantly related to the severity of ill-
ness on Day 1 as reflected by the TISS-28, indicating
that the severity of disease at admission predicts func-
tional outcome one year after discharge. Therefore, the
initial TISS-28 may be used to help decide whether
invasive therapeutic procedures such as hemicraniect-
omy in malignant middle cerebral artery infarction
ought to be carried out.
The admission diagnoses of GBS and myasthenia
gravis were related to good functional outcome one year
after discharge. Compared to patients with a benign dis-
ease course, patients with rapidly progressive neuromus-
cular weakness, dysautonomia and those requiring
ventilation, thus requiring NICU admission, are known
to have a less favorable outcome [24-26]. However,
compared to irreversible central nervous system dis-
eases, patients with GBS and MG who require neurocri-
tical care tend to have a better functional outcome after
one year. This is mainly based on the potentially reversi-
ble character of these diseases and the substantial pro-
gress in therapy within the last decades [27,28]. In
contrast, patients with seizures did not reach statistical
trends towards a good outcome. The finding that not all
of the potentially reversible diseases showed a good out-
come is most likely related to underlying severe co-mor-
bidity [29,30], for example, symptomatic seizures after a
stroke with a mortality of nearly 20% [31,32].
The diagnosis of ICH, often associated with intraven-
tricular hemorrhage, was associated with both the
Table 2 Predictors for functional outcome
Good outcome (mRS ≤
2)
Exp(Coef) 95% CI P-value
Univariate
Age 0.834 0.794 to 0.872 <
0.0001
SEX (female) 1.265 0.554 to 1.864 0.57645
Hospital LOS 0.759 0.281 to
0.866
0.04397
Length of ventilation 0.410 0.113 to
0.641
0.01202
Length of ventilation (per
increasing day)
0.974 0.913 to 1.061 0.09441
TISS-28 on Day 1
< 21 2.746 1.935 to
4.391
0.00666
20 to 40 1.273 0.764 to
1.812
0.21932
> 40 0.715 0.621 to
0.944
0.00181
TISS-28 at discharge
< 21 2.187 1.453 to
3.812
0.01215
20 to 40 1.234 0.218 to
2.187
0.23156
> 40 0.711 0.451 to
0.857
0.00017
Ischemia 0.724 0.485 to
0.932
0.04275
ICH 0.743 0.573 to
0.935
0.02046
SAH 0.636 0.273 to 1.198 0.63532
Meningoencephalitis 1.412 0.996 to 3.238 0.12432
Epilepsy 1.433 0.233 to 2.346 0.73255
GBS/MG 3.623 1.124 to
13.327
0.00145
Neurodeg./Encephalopathy 0.680 0.274 to 1.019 0.05723
Neoplasm 0.692 0.371 to
0.856
0.00039
Intoxication 5.809 1.832 to
7.483
0.03881
Multivariate
Age 0.786 0.435 to 0.823 0.00245
Hospital LOS 0.509 0.272 to 1.279 0.17647
Length of ventilation 0.681 0.475 to
0.912
0.00354
TISS-28 on Day 1 > 40 0.815 0.578 to
0.931
0.00187
Ischemia 0.345 0.245 to 1.101 0.11458
ICH 0.643 0.218 to
0.877
0.03874
GBS/MG 2.215 2.006 TO
3.214
0.03329
Neurodeg./Encephalopathy 0.705 0.297 to 1.354 0.15478
Neoplasm 0.687 0.354 to
0.934
0.04875
Intoxication 1.399 0.964 to 2.648 0.27261
Univariate and multivariate regression analysis for parameters predicting a
good functional outcome (mRS 0 to 2) one year after neurocritical care.
Analysis of all patients receiving specialized neurocritical care (n = 666).
Parameters that reached significance (P < 0.05) are expressed in bold.
Parameters that showed a statistical trend (P < 0.1) in the univariate analysis
are expressed in italics.
Abbreviations: CI, confidence interval; LOS, length of stay; ICH, intracranial
hemorrhage; SAH, subarachnoid hemorrhage; GBS, Guillain-Barré syndrome;
MG, myasthenia gravis; Neurodeg, neurodegenerative disease
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year. This finding was in line with previous reports [3]
and indicates that, while some patients with ICH
improve clinically [33], the overall functional status of
patients with this diagnosis deteriorates. ICH leads to
substantial disability itself, causing reduced levels of
consciousness, mechanical ventilation and extended ICU
stay which again cause further complications, high early
mortality and generally poor functional outcome [34,35].
Length of ventilation
The LOV was independently predictive for a negative
outcome. This feature has not yet been described. The
length of hospital stay (LOS) showed a significant asso-
ciation with outcome in the univariate analysis but did
not, as shown before [1,3,36], independently predict
poor outcome and hence LOV, rather than LOS may
serve as a surrogate marker for disease severity. This is
most likely related to the fact that patients who required
prolonged ventilation, per definition, had a longer LOS,
whereas patients with prolonged LOS were not always
mechanically ventilated and the LOS was occasionally
affected by the availability of beds on other wards and
rehabilitation centres. This aspect, that LOV rather than
LOS reflects disease severity, might be focussed on in
f u t u r es t u d i e sa si ta p p e a r sl i k e l yt h a tt h e r ea r ed i f f e r -
ences regarding the specific diseases.
Limitations
The data presented have certain shortcomings, mainly
the retrospective design of the study and the loss of
some patients to follow-up analysis. Moreover, changes
in staffing of our ICU might have altered treatment stra-
tegies and led to changes in outcomes. Outcome was
assessed one year after neurocritical care, however,
mailed questionnaires filled-out by patients or their rela-
tives have an inherent predisposition for inaccuracy with
respect to the validity of mRS estimation [37,38].
Further criticism might arise due to the rather rigorous
cut-off rate we defined for outcome definition (that is,
mRS ≤ 2 for good outcome). We aimed to identify only
those patients who were functionally independent with-
out requiring assistance for their daily activities. Other
neurological studies which referred to the functional
outcome as a primary endpoint have not necessarily
used the same cut-off points [3,6]. Moreover, other
important parameters possibly influencing outcome,
such as GCS on admission or the requirement of intra-
venous catecholamines, were not sufficiently assessable
in this retrospective analysis. Finally, the impact of reha-
bilitation was not assessed which may have influenced
the results on functional outcome after neurocritical
care.
Conclusions
Although this appears counterintuitive, functional out-
come and mortality of patients treated in specialized
NICU units compare favourably with those in other
intensive care fields. This highlights the impact of spe-
cialized neurocritical care procedures. The data pre-
sented here suggest that age, admission diagnosis, TISS-
28 on Day 1, and length of ventilation are important
independent predictors for outcome in neurocritical
care patients. However, more disease-specific prognostic
information on clinical course and functional outcome
are needed to guide neurocritical care physicians in
their identification process of patients who benefit from
neurocritical care, and to possibly confine extended
neurocritical treatment in certain situations, respectively.
Key messages
￿ In neurocritical care, disease-specific prognostic
information on clinical course and functional out-
come are needed to guide neurocritical care physi-
cians in their identification process of patients who
benefit from neurocritical care.
￿ In this large, consecutive neurointensive care
patient cohort, the diseases GBS and MG were inde-
pendently related to a good long-term outcome,
whereas older age and increased length of ventilation
as well as the diagnoses ICH and cerebral neoplasm
were predisposing factors for an unfavorable
outcome.
Abbreviations
DNT: do not treat; GBS: Guillain-Barré syndrome; GCS: Glasgow Coma Scale;
ICH: intracranial hemorrhage; ICU: intensive care unit; LOS: length of hospital
stay; LOV: duration time of ventilation; MG: myasthenia gravis; mRS: modified
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